Effect of deletion of epidermal growth factor-like domain on plasma clearance of pro-urokinase
- 1 July 1989
- journal article
- research article
- Published by Elsevier in Fibrinolysis
- Vol. 3 (3) , 147-151
- https://doi.org/10.1016/0268-9499(89)90012-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue-type plasminogen activator in rabbitsBlood, 1988
- Autocrine saturation of pro-urokinase receptors on human A431 cellsCell, 1986
- Establishment of passive hemagglutination assay (PHA) system for anti-HBc in plasma.The Tohoku Journal of Experimental Medicine, 1986
- Catabolism of human tissue plasminogen activator in miceBlood, 1985
- A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.The Journal of cell biology, 1985
- In vivo metabolism of human tissue‐type plasminogen activatorScandinavian Journal of Haematology, 1984
- Purification and partial characterization of a single-chain high-molecular-weight form of urokinase from human urineArchives of Biochemistry and Biophysics, 1983
- Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibodyBiochemistry, 1982
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- The Peptide Chains of Human PlasminJournal of Biological Chemistry, 1967